n-acetylsphingosine has been researched along with s-nitroso-n-acetylpenicillamine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barsacchi, R; Cantoni, O; Clementi, E; De Nadai, C; Lièvremont, JP; Meldolesi, J; Moncada, S; Sciorati, C; Sestili, P | 1 |
Eguchi, K; Hida, A; Huang, M; Ida, H; Izumi, Y; Kawakami, A; Miyashita, T; Nakamura, H; Nakashima, K; Origuchi, T; Tamai, M; Tanaka, F; Ueki, Y; Yamasaki, S | 1 |
2 other study(ies) available for n-acetylsphingosine and s-nitroso-n-acetylpenicillamine
Article | Year |
---|---|
Nitric oxide inhibits tumor necrosis factor-alpha-induced apoptosis by reducing the generation of ceramide.
Topics: Antigens, CD; Apoptosis; Caspase 8; Caspase 9; Caspases; Ceramides; Cyclic GMP; Enzyme Inhibitors; Humans; Kinetics; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Penicillamine; Proteins; Quinoxalines; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; S-Nitroso-N-Acetylpenicillamine; Second Messenger Systems; Signal Transduction; Sphingosine; TNF Receptor-Associated Factor 1; Tumor Necrosis Factor-alpha; U937 Cells | 2000 |
Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis.
Topics: Apoptosis; Arthritis, Rheumatoid; Caspases; Cell Division; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Etoposide; Humans; Leupeptins; Mitochondria; Nitric Oxide; Nitric Oxide Donors; S-Nitroso-N-Acetylpenicillamine; Sphingosine | 2004 |